According to Fortune Business Insights, the global stereotactic surgery devices market was valued at USD 29.59 billion in 2025 and is projected to grow from USD 31.18 billion in 2026 to USD 47.34 billion by 2034, exhibiting a CAGR of 5.36% during the forecast period. The increasing prevalence of neurological disorders, growing adoption of minimally invasive surgical procedures, and advancements in image-guided technologies are driving market expansion worldwide.
Stereotactic surgery devices are advanced medical systems used to perform highly precise surgical interventions within the brain and other anatomical structures. These devices utilize three-dimensional coordinate systems combined with imaging technologies such as MRI and CT scans to accurately target lesions, tumors, and neurological abnormalities. Their ability to minimize damage to surrounding tissues has made them a preferred choice for neurosurgeons and radiation oncologists.
The increasing incidence of brain tumors, epilepsy, Parkinson’s disease, and arteriovenous malformations has significantly increased the demand for stereotactic surgery devices. Healthcare providers are increasingly investing in advanced neurosurgical infrastructure to improve patient outcomes and reduce procedural risks.
The growing burden of neurological diseases worldwide remains one of the key factors fueling market growth. Brain tumors, epilepsy, movement disorders, and chronic neurological conditions continue to increase due to aging populations and lifestyle-related health issues. Stereotactic surgery offers a minimally invasive solution with superior precision, making it an attractive treatment option.
Patients and healthcare providers are increasingly favoring minimally invasive surgeries due to shorter hospital stays, reduced complications, and faster recovery times. Stereotactic surgery devices provide sub-millimeter accuracy, allowing surgeons to treat complex conditions while minimizing trauma to healthy tissues.
Recent innovations in MRI-guided surgery, robotic-assisted interventions, AI-based navigation systems, and real-time tracking technologies are enhancing procedural accuracy and treatment effectiveness. These advancements are improving surgical outcomes and encouraging wider adoption across healthcare facilities.
Frameless stereotactic systems are gaining popularity due to enhanced patient comfort and reduced setup times. Unlike traditional frame-based procedures, these systems provide flexibility while maintaining high precision, making them suitable for a broader range of clinical applications.
Artificial intelligence is transforming stereotactic surgery through advanced image analysis, automated treatment planning, and enhanced navigation capabilities. AI-assisted systems help improve targeting accuracy and reduce procedural complexities, supporting better patient outcomes.
The healthcare industry is witnessing increased demand for outpatient treatments due to cost efficiency and patient convenience. Stereotactic procedures are increasingly being performed in ambulatory surgical centers, creating new growth opportunities for device manufacturers.